ArticlePatient preference and adherence2021

Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study.

Judith J Stephenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.